Prevalence and Risk Factors of Infection in the Representative COVID-19 Cohort Munich.

COVID-19 SARS-CoV-2 infection fatality ratio population-based cohort study seroprevalence underreporting

Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
30 03 2021
Historique:
received: 18 02 2021
revised: 23 03 2021
accepted: 27 03 2021
entrez: 3 4 2021
pubmed: 4 4 2021
medline: 10 4 2021
Statut: epublish

Résumé

Given the large number of mild or asymptomatic SARS-CoV-2 cases, only population-based studies can provide reliable estimates of the magnitude of the pandemic. We therefore aimed to assess the sero-prevalence of SARS-CoV-2 in the Munich general population after the first wave of the pandemic. For this purpose, we drew a representative sample of 2994 private households and invited household members 14 years and older to complete questionnaires and to provide blood samples. SARS-CoV-2 seropositivity was defined as Roche N pan-Ig ≥ 0.4218. We adjusted the prevalence for the sampling design, sensitivity, and specificity. We investigated risk factors for SARS-CoV-2 seropositivity and geospatial transmission patterns by generalized linear mixed models and permutation tests. Seropositivity for SARS-CoV-2-specific antibodies was 1.82% (95% confidence interval (CI) 1.28-2.37%) as compared to 0.46% PCR-positive cases officially registered in Munich. Loss of the sense of smell or taste was associated with seropositivity (odds ratio (OR) 47.4; 95% CI 7.2-307.0) and infections clustered within households. By this first population-based study on SARS-CoV-2 prevalence in a large German municipality not affected by a superspreading event, we could show that at least one in four cases in private households was reported and known to the health authorities. These results will help authorities to estimate the true burden of disease in the population and to take evidence-based decisions on public health measures.

Identifiants

pubmed: 33808249
pii: ijerph18073572
doi: 10.3390/ijerph18073572
pmc: PMC8038115
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Bavarian State Ministry of Science and the Arts
ID : n/a
Organisme : University Hospital, LMU Munich
ID : n/a
Organisme : Helmholtz Centre Munich
ID : n/a
Organisme : University of Bonn
ID : n/a
Organisme : University of Bielefeld
ID : n/a
Organisme : German Ministry for Education and Research
ID : MoKoCo19, 01KI20271

Références

PLoS One. 2020 Aug 14;15(8):e0237833
pubmed: 32797108
Science. 2020 Nov 6;370(6517):691-697
pubmed: 33154136
Lancet. 2020 Aug 1;396(10247):313-319
pubmed: 32534626
Med (N Y). 2021 Feb 12;2(2):149-163.e4
pubmed: 33163984
Am J Public Health. 2020 Jul;110(7):949-951
pubmed: 32324422
Lancet Infect Dis. 2021 Apr;21(4):e69-e70
pubmed: 32679085
Clin Chem Lab Med. 2020 Aug 27;58(12):2121-2130
pubmed: 32853163
Int J Infect Dis. 2020 Dec;101:138-148
pubmed: 33007452
Am J Epidemiol. 2021 Jan 4;190(1):109-115
pubmed: 32803245
BMC Public Health. 2020 Jun 30;20(1):1036
pubmed: 32605549
Trends Microbiol. 2016 Feb;24(2):123-133
pubmed: 26612500
Hum Brain Mapp. 2002 Jan;15(1):1-25
pubmed: 11747097
OTO Open. 2020 Sep 11;4(3):2473974X20957975
pubmed: 32964177
N Engl J Med. 2020 Oct 29;383(18):1724-1734
pubmed: 32871063
Clin Exp Allergy. 2020 Dec;50(12):1313-1324
pubmed: 32975865
Nat Commun. 2020 Nov 17;11(1):5829
pubmed: 33203887
BMC Med Res Methodol. 2020 Jul 9;20(1):187
pubmed: 32646374
Science. 2020 Oct 23;370(6515):406-407
pubmed: 33093098
N Engl J Med. 2020 Mar 5;382(10):970-971
pubmed: 32003551
Lancet. 2020 Aug 22;396(10250):535-544
pubmed: 32645347

Auteurs

Michael Pritsch (M)

Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany.
German Center for Infection Research (DZIF), Partner Site Munich, 80802 Munich, Germany.

Katja Radon (K)

Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, University Hospital, LMU Munich, 80336 Munich, Germany.
Center for International Health (CIH), University Hospital, LMU Munich, 80336 Munich, Germany.
Comprehensive Pneumology Center (CPC) Munich, German Center for Lung Research (DZL), 89337 Munich, Germany.

Abhishek Bakuli (A)

Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany.

Ronan Le Gleut (R)

Helmholtz Zentrum München-German Research Center for Environmental Health, Institute of Computational Biology, 85764 Neuherberg, Germany.
Helmholtz Zentrum München-German Research Center for Environmental Health, Core Facility Statistical Consulting, 85764 Neuherberg, Germany.

Laura Olbrich (L)

Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany.
German Center for Infection Research (DZIF), Partner Site Munich, 80802 Munich, Germany.

Jessica Michelle Guggenbüehl Noller (JM)

Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany.

Elmar Saathoff (E)

Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany.
German Center for Infection Research (DZIF), Partner Site Munich, 80802 Munich, Germany.

Noemi Castelletti (N)

Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany.

Mercè Garí (M)

Helmholtz Zentrum München-German Research Center for Environmental Health, Institute of Computational Biology, 85764 Neuherberg, Germany.

Peter Pütz (P)

Helmholtz Zentrum München-German Research Center for Environmental Health, Institute of Computational Biology, 85764 Neuherberg, Germany.
Faculty of Business Administration and Economics, Bielefeld University, 33615 Bielefeld, Germany.

Yannik Schälte (Y)

Helmholtz Zentrum München-German Research Center for Environmental Health, Institute of Computational Biology, 85764 Neuherberg, Germany.
Center for Mathematics, Technische Universität München, 85748 Garching, Germany.

Turid Frahnow (T)

Helmholtz Zentrum München-German Research Center for Environmental Health, Institute of Computational Biology, 85764 Neuherberg, Germany.
Faculty of Business Administration and Economics, Bielefeld University, 33615 Bielefeld, Germany.

Roman Wölfel (R)

German Center for Infection Research (DZIF), Partner Site Munich, 80802 Munich, Germany.
Bundeswehr Institute of Microbiology, 80937 Munich, Germany.

Camilla Rothe (C)

Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany.

Michel Pletschette (M)

Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany.

Dafni Metaxa (D)

Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany.

Felix Forster (F)

Institute and Outpatient Clinic for Occupational, Social and Environmental Medicine, University Hospital, LMU Munich, 80336 Munich, Germany.
Comprehensive Pneumology Center (CPC) Munich, German Center for Lung Research (DZL), 89337 Munich, Germany.

Verena Thiel (V)

Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany.

Friedrich Rieß (F)

Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany.
German Center for Infection Research (DZIF), Partner Site Munich, 80802 Munich, Germany.

Maximilian Nikolaus Diefenbach (MN)

Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany.

Günter Fröschl (G)

Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany.
Center for International Health (CIH), University Hospital, LMU Munich, 80336 Munich, Germany.

Jan Bruger (J)

Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany.

Simon Winter (S)

Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany.

Jonathan Frese (J)

Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany.

Kerstin Puchinger (K)

Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany.

Isabel Brand (I)

Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany.

Inge Kroidl (I)

Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany.
German Center for Infection Research (DZIF), Partner Site Munich, 80802 Munich, Germany.

Jan Hasenauer (J)

Helmholtz Zentrum München-German Research Center for Environmental Health, Institute of Computational Biology, 85764 Neuherberg, Germany.
Center for Mathematics, Technische Universität München, 85748 Garching, Germany.
Interdisciplinary Research Unit Mathematics and Life Sciences, University of Bonn, 53113 Bonn, Germany.

Christiane Fuchs (C)

Helmholtz Zentrum München-German Research Center for Environmental Health, Institute of Computational Biology, 85764 Neuherberg, Germany.
Helmholtz Zentrum München-German Research Center for Environmental Health, Core Facility Statistical Consulting, 85764 Neuherberg, Germany.
Faculty of Business Administration and Economics, Bielefeld University, 33615 Bielefeld, Germany.
Center for Mathematics, Technische Universität München, 85748 Garching, Germany.

Andreas Wieser (A)

Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany.
German Center for Infection Research (DZIF), Partner Site Munich, 80802 Munich, Germany.

Michael Hoelscher (M)

Division of Infectious Diseases and Tropical Medicine, University Hospital, LMU Munich, 80802 Munich, Germany.
German Center for Infection Research (DZIF), Partner Site Munich, 80802 Munich, Germany.
Center for International Health (CIH), University Hospital, LMU Munich, 80336 Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH